内美通联合促性腺激素释放激素激动剂治疗子宫内膜异位症的临床研究OA
Gestrinone combined with gonadotropin-releasing hormone agonist for endometriosis
目的 研究观察内美通联合促性腺激素释放激素激动剂( GnRH-a)治疗子宫内膜异位症的临床疗效.方法 将我院收治的80例子宫内膜异位症患者随机均分为两组:观察组给予内美通联合GnRH-a治疗,对照组给予GnRH-a治疗.观察两组患者的症状、体征和盆腔超声检查等,并进行分析.结果 观察组中有36例完全治愈,3例缓解,1例复发；对照组有29例完全治愈,9例缓解,2例复发.两组比较差异有统计学意义(P＜ 0.05).服药后的毒副作用在阴道出血、ALT升…查看全部>>
Objective To observe the clinical efficacy of gonadotropin-releasing hormone agonist ( GnRH-a ) combined with gestrinone in the treatment of endometriosis.Methods 80 patients with endometriosis were randomly assigned to receive gestrinone combined with GnRH-a ( study group ),or GnRH-a alone ( control group ).The symptoms,signs, and findings of pelvic ultrasonic examination were observed and analyzed.Results In the study group, 36 patients were cured,3 had…查看全部>>
张倩君
511400 广州市番禺区何贤纪念医院妇产科
内美通促性腺激素释放激素激动剂子宫内膜异位症临床研究
GestrinoneGonadotropin-releasing hormone agonistEndometriosisClinical research
《国际医药卫生导报》 2012 (9)
1286-1288,3
评论